Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Fountain Pharmaceuticals (FPHI) -- Ignore unavailable to you. Want to Upgrade?

To: r. peter Dale who wrote (60)	1/7/1998 4:13:00 PM
From: Courtney Willfore	Read Replies (1) \| Respond to of 78

Peter - Fountain is up ~70% so far this week. Maybe, just maybe, someone really is taking your suggestion (Ariad) seriously. CW

To: r. peter Dale who wrote (60)	6/12/2002 2:34:15 PM
From: scaram(o)uche	Respond to of 78

r. Peter/Courtney/Ron/Scott/Wesley/etc....... just FYI, yet another hoax....... Wednesday June 12, 12:55 pm Eastern Time Associated Press Hoaxer Strikes Online News Service Hoaxer Strikes Online News Service With Bogus Release in Possible Stock Scheme NEW YORK (AP) -- An unidentified hoaxer got the Internet Wire online press-release service to publish a bogus news release about a tiny drug company this week, in what may have been an attempt to manipulate the stock. ADVERTISEMENT The phony release Monday caused a short-lived jump in shares of Cel-Sci Corp. Internet Wire and Cel-Sci both said they didn't know who was behind the false release, which has since been retracted. The companies have referred the matter to the Securities and Exchange Commission, which has declined to comment. The incident is reminiscent of a widely publicized case in 2000 in which a hoaxer drove Emulex Corp. shares lower by getting Internet Wire to distribute a false negative release about the maker of data-storage products. After that incident, Internet Wire vowed to tighten its security to assure that all its releases were genuine. Internet Wire on Tuesday blamed the release of the bogus press release on an employee's failure to follow its procedures. The company defended its procedures, and said it was "frustrating" that it had been victimized again despite the procedures, which include authenticating phone calls. "It's damn difficult to stop this stuff," said Jim McGovern, Internet Wire's chief executive. "We're going to reexamine what else we can do." The Cel-Sci release, which Internet Wire published early Monday morning, purported to announce a partnership between Cel-Sci and Japan's Takeda Chemical Industries Ltd. to develop Multikine, Cel-Sci's immune-therapy drug. As described in the release, the deal would have provided Cel-Sci with up to $520 million in cash, equity and convertible notes. That would have been a windfall for a company that had only $670,000 in revenue in its most recent fiscal year, and which has cash and investment securities of only $2.4 million on its balance sheet. The release boosted Cel-Sci's stock Monday to 31 cents a share from 29 cents; the stock went as high as 37 cents during the day. Trading volume was 1.3 million shares, more than five times the average volume for Cel-Sci, a biopharmaceuticals concern based in Vienna, Va. Geert Kersten, Cel-Sci's chief executive, said the company doesn't have a relationship with Takeda, much less the lucrative one cited in the release. Cel-Sci informed Internet Wire that the release was a fake, and Internet Wire issued a retraction after the market closed Monday. Kersten said he doesn't know who was behind the hoax, and isn't even sure that the purpose was to goose Cel-Sci's stock. In midday trading, shares of Cel-Sci were at 30 cents, unchanged on the American Stock Exchange.

To: r. peter Dale who wrote (60)	6/24/2002 11:46:37 AM
From: scaram(o)uche	Respond to of 78

Monday June 24, 11:28 am Eastern Time Trader Settles With SEC Over Alleged Stock Shenanigans By: Judith Burns, Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- A Virginia day trader agreed to settle Securities and Exchange Commission allegations he manipulated a half-dozen stocks in online, after-hours trading. Kin Lee, a self-employed day trader, didn't admit or deny the SEC's allegations, but agreed to pay a $60,000 fine and return more than $100,000 of allegedly ill-gotten gains. The settlement also bars Lee from future day- trading activity. Lee used a computer in his McLean, Va., home to buy and sell stocks through numerous online brokerage accounts he controlled under various aliases, according to the SEC's case filed Monday in federal court in Virginia . The day trader waited until U.S. markets closed, then bought stocks through one of his accounts and sold the shares to another to create the illusion of activity, a practice known as "wash" trading. To further the illusion, the SEC said Lee placed numerous limit orders to buy or sell stocks at preset prices, setting the price at unrealistically high or low levels. These "phantom" orders had little chance of being executed, but the SEC said posting them made the market appear to be more active than it actually was. "What used to be done with boiler rooms and bucket shops can now be done online," said John Reed Stark, director of the SEC's Internet enforcement unit, in Washington . He said Lee ran "a classic manipulation," to artificially inflate stock prices. The only difference, said Stark, is that Lee relied on " 21st century technology" to conduct the alleged fraud, which the SEC said started in January 2000 and continued until April 2001 . Lee allegedly manipulated prices in Consulier Engineering Inc. , Biospecifics Technologies Corp. , Hawk Industries Inc. (HAWK), FTD.com Inc. (EFTD), Pharmaprint, Inc. (PPRT) and Eprise Inc. (EPRS), according to the SEC.

To: r. peter Dale who wrote (60)	6/25/2002 1:09:57 PM
From: scaram(o)uche	Respond to of 78

Ron/Scott/r. Peter/Courtney/etc., etc.: Library computers seem to be popular....... Tuesday June 25, 11:04 am Eastern Time Georgia Teenager Settles Bogus Online Posting Case By: Judith Burns, Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- A Georgia teenager settled a Securities and Exchange Commission proceeding Tuesday claiming he posted a bogus news story on Internet message boards last month to boost shares of Viragen International Inc. (VGNI). Benjamin Snyder, a 17-year-old high school student, settled the matter without admitting or denying SEC allegations he created a fake Bloomberg.com news article reporting that the Food and Drug Administration had approved a Viragen International drug to treat anthrax. The bogus news story, which carried the name of a real Bloomberg reporter, said Viragen's stock was expected to multiply six- or seven-fold. "It was absolutely false," said John Reed Stark, director of Internet enforcement at the SEC in Washington , D.C . "It was an effort to capitalize on the anthrax scare." The scheme didn't work, however. SEC officials said there was no evidence the postings on the popular Raging Bull message boards generated any interest in the stock. "We found no one who read the postings and believed them," said Stark. In fact, he said one reader alerted the SEC to the postings as a possible scam. Snyder used a computer at the Lawrenceville, Ga., public library on May 13 to spread the fake report, the SEC said. The teenager owned about $500 of stock in Viragen, bought through an account opened by his father, a Lawrenceville, Ga., minister. When the first posting failed to budge the stock price, Snyder posted the story again, two days later, regulators said. Stark said Snyder's attempts to manipulate the stock market and evade detection by using the library's computer failed completely. "We caught him in about a day and a half." Snyder admitted to the alleged scheme and, since he made no profit on it, the SEC didn't impose any fine or require him to fork over any ill-gotten gains.